Edition:
India

Laurus Labs Ltd (LAUL.NS)

LAUL.NS on National Stock Exchange of India

543.65INR
19 Jan 2018
Change (% chg)

Rs6.50 (+1.21%)
Prev Close
Rs537.15
Open
Rs540.80
Day's High
Rs546.00
Day's Low
Rs535.00
Volume
60,431
Avg. Vol
101,838
52-wk High
Rs640.00
52-wk Low
Rs418.90

Chart for

About

Laurus Labs Limited, formerly Laurus Labs Pvt Ltd, is an India-based research and development pharmaceutical company. The Company is a manufacturer of active pharmaceutical ingredients (APIs) for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas. Its business units include... (more)

Overall

Beta: --
Market Cap(Mil.): Rs57,404.51
Shares Outstanding(Mil.): 106.03
Dividend: 1.50
Yield (%): 0.28

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Laurus labs gets EIR from US FDA for Visakhapatnam units

* Gets EIR from US FDA for unit 1, 3, at Parawada, Visakhapatnam, for inspection conducted in August 2017​ Source text for Eikon: Further company coverage:

14 Nov 2017

BRIEF-India's Laurus Labs Sept-qtr consol profit rises

* Sept quarter consol net profit 487.6 million rupees versus 482.8 million rupees year ago

09 Nov 2017

BRIEF-Laurus Labs gets EIR from U.S. FDA for plant at unit 2 in Atchutapuram

* Gets EIR from U.S. FDA for its finished dosage formulations & active pharmaceutical ingredients plant, unit 2, located at Atchutapuram

15 Sep 2017

BRIEF-India's Laurus Labs June-qtr consol profit rises

* June quarter consol net profit 389.1 million rupees versus 256.4 million rupees year ago

10 Aug 2017

Earnings vs. Estimates